Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
HNF1α maintains pancreatic α and β cell functions in primary human islets
Mollie F. Qian, … , Patrick E. MacDonald, Seung K. Kim
Mollie F. Qian, … , Patrick E. MacDonald, Seung K. Kim
Published November 9, 2023
Citation Information: JCI Insight. 2023;8(24):e170884. https://doi.org/10.1172/jci.insight.170884.
View: Text | PDF
Research Article Endocrinology Genetics

HNF1α maintains pancreatic α and β cell functions in primary human islets

  • Text
  • PDF
Abstract

HNF1A haploinsufficiency underlies the most common form of human monogenic diabetes (HNF1A–maturity onset diabetes of the young [HNF1A-MODY]), and hypomorphic HNF1A variants confer type 2 diabetes risk. But a lack of experimental systems for interrogating mature human islets has limited our understanding of how the transcription factor HNF1α regulates adult islet function. Here, we combined conditional genetic targeting in human islet cells, RNA-Seq, chromatin mapping with cleavage under targets and release using nuclease (CUT&RUN), and transplantation-based assays to determine HNF1α-regulated mechanisms in adult human pancreatic α and β cells. Short hairpin RNA–mediated (shRNA-mediated) suppression of HNF1A in primary human pseudoislets led to blunted insulin output and dysregulated glucagon secretion after transplantation in mice, recapitulating phenotypes observed in patients with diabetes. These deficits corresponded with altered expression of genes encoding factors critical for hormone secretion, including calcium channel subunits, ATPase transporters, and extracellular matrix constituents. Additionally, HNF1A loss led to upregulation of transcriptional repressors, providing evidence for a mechanism of transcriptional derepression through HNF1α. CUT&RUN mapping of HNF1α DNA binding sites in primary human islets imputed a subset of HNF1α-regulated genes as direct targets. These data elucidate mechanistic links between HNF1A loss and diabetic phenotypes in mature human α and β cells.

Authors

Mollie F. Qian, Romina J. Bevacqua, Vy M.N. Coykendall, Xiong Liu, Weichen Zhao, Charles A. Chang, Xueying Gu, Xiao-Qing Dai, Patrick E. MacDonald, Seung K. Kim

×

Figure 3

RNA-Seq of HNF1AKD β cells shows that HNF1α regulates insulin secretion, metabolism, developmental pathways, and cell-to-cell signaling in β cells.

Options: View larger image (or click on image) Download as PowerPoint
RNA-Seq of HNF1AKD β cells shows that HNF1α regulates insulin secretion,...
(A) Schematic of FACS scheme for isolation of transduced live β cells (HPi2+GFP+NTPDase3+) from control and HNF1AKD pseudoislets for downstream RNA-Seq (n = 4 donors). (B) Fraction of endocrine (HPi2+) cells expressing GFP in sorted samples. (C) HNF1A transcripts per million (TPM) in sequenced samples. (D) Differential expression analysis revealed significantly up- and downregulated genes after HNF1AKD in β cells. Fold change (FC) = 1.5, adjusted P = 0.05. (E) Heatmap of DEGs in β cells after HNF1AKD. (F–H) Significantly downregulated (F) and upregulated (G) Gene Ontology (GO) pathways and downregulated KEGG pathways (H) in HNF1AKD relative to control β cells. *P < 0.05.

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts